Status:
COMPLETED
Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief
Lead Sponsor:
Region Skane
Conditions:
Angina
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
Nasal oxygen is widely used as pain relief against ischemic pain during Percutaneous Coronary Intervention (PCI). However, to our knowledge no randomised clinical trials have tested this. In contrast,...
Eligibility Criteria
Inclusion
- Stable angina or NST-ACS undergoing PCI
Exclusion
- Blood oxygen \<95%
- Cognitive dysfunction
- STEMI
- Intubation
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01413841
Start Date
July 1 2011
End Date
June 1 2012
Last Update
August 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skane University Hospital, Lund
Lund, Sweden, 22185